VivoTherapeutics (VIVO) is a specialized pharmaceutical company that focuses on the registration, and promotion of unique biotechnology and pharmaceutical products. Our extensive product line includes impactful branded generics, biosimilars, orphan medicines, and innovative drugs. By combining these diverse specialties, we remain committed to surpassing our customers' expectations in terms of value, quality, and service.

Since our establishment, we have dedicated ourselves to supplying pharmaceutical and biological niche drugs in key areas such as Hemat-Oncology, Oncology, Infectious Diseases and CNS Diseases. To ensure widespread availability, VIVO has established a network of reputable distributors and wholesalers that cater to the private market. Additionally, we take full responsibility for regulatory compliance, sales, and marketing efforts in government tenders, hospitals, and institutional segments.

Our strength lies in our in-depth knowledge of local markets, our ability to identify areas with unmet medical needs, and our experienced sales organization. We are deeply committed to the well-being of the patients we serve. Throughout our tenure, we have actively contributed effective solutions to address barriers related to education, access, and affordability, thereby instilling hope, and enhancing the quality of life for patients.